Target intelligence / Profile preview

Enterotoxigenic Escherichia coli flagellin (FliC) (FliC)

Target
FliC
Molecular classification
Bacterial protein, Structural protein, Toll-like receptor 5 (TLR5) agonist, Antigen
01

Overview

Enterotoxigenic Escherichia coli (ETEC) flagellin, primarily the FliC protein, is the major structural subunit of the bacterial flagellum, essential for motility and chemotaxis (UniProt: P0AEE8). In ETEC pathogenesis, flagellin enables the bacteria to penetrate the intestinal mucus layer and reach the epithelial surface for colonization (PubMed: 25643275). It serves as a potent Pathogen-Associated Molecular Pattern (PAMP) recognized by Toll-like receptor 5 (TLR5), which induces the secretion of pro-inflammatory cytokines such as IL-8 (PubMed: 11591737). Because of its critical role in infection and its high immunogenicity, flagellin is a primary target for vaccine development, including oral whole-cell vaccines like ETVAX and recombinant subunit vaccines (PubMed: 31235471). Furthermore, its TLR5-agonistic properties allow it to function as an effective adjuvant to boost immune responses against other ETEC antigens (PubMed: 28807975). Targeting flagellin aims to both block bacterial motility and stimulate a robust mucosal immune response to prevent diarrheal disease.

Other names
Flagellar filament structural proteinH-antigenFliC proteinFlagellin
02

Mechanism of action

Flagellin acts as an immunogen that induces the production of H-antigen-specific antibodies to inhibit bacterial motility and colonization. It also functions as a TLR5 agonist, activating the MyD88-dependent signaling pathway to stimulate innate immune defenses and enhance the adaptive response to co-administered antigens (PubMed: 11591737, 28807975).

03

Biological functions

Bacterial motilityChemotaxisCellular adhesionInnate immune activationPro-inflammatory signaling
04

Disease associations

InfectionTraveler's diarrheaChildhood diarrheaInflammation
05

Safety considerations

Systemic inflammatory response (cytokine storm) if administered parenterallyGastrointestinal reactogenicity in oral formulationsPotential for molecular mimicry with host proteinsStrain-specific variation in flagellin sequences (H-serotypes)
06

Interacting drugs

ETVAX

2 more in the full profile.

07

Biomarkers

Anti-H-antigen IgG titersAnti-H-antigen secretory IgA (sIgA) titersInterleukin-8 (IL-8) levelsTLR5 expression levels

Beyond the preview

Go deeper on Enterotoxigenic Escherichia coli flagellin (FliC) (FliC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterotoxigenic Escherichia coli flagellin (FliC) (FliC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call